Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Clin Endocrinol (Oxf). 2010 Feb 10;73(2):201–205. doi: 10.1111/j.1365-2265.2010.03781.x

Table 1.

Baseline characteristics by hypertension incidence status

Persistent
Normotensives
(n = 496)
New
hypertensives
(n = 106)
P
Mean age (yrs) 65.4 ± 12.0 69.9 ± 8.2 <0.001
Men - n (%) 308 (62.1) 57 (53.8) 0.11
Regular exercise - n (%) 397 (80.5) 92 (86.8) 0.12
Current smoke - n (%) 70 (14.1) 12 (11.3) 0.45
Alcohol (3 times/week) - n (%) 228 (46) 48 (45.2) 0.90
Body mass index (kg/m2) 24.9 ± 3.5 25.0 ± 3.4 0.82
Waist circumference (cm) 86.2 ± 11.4 86.9 ± 11.0 0.59
Systolic blood pressure (mm Hg) 121.0 ± 9.2 129.4 ± 7.0 <0.001
Diastolic blood pressure (mm Hg) 72.9 ± 7.4 74.1 ± 7.4 0.13
Fasting blood glucose (mmol/L) 5.46 ± 0.99 5.76 ± 1.97 0.13
Total cholesterol (mmol/L) 5.60 ± 1.04 5.87 ± 1.17 0.01
LDL-c (mmol/L) 3.50 ± 0.95 3.74 ± 1.06 0.02
HDL-c (mmol/L) 1.53 ± 0.48 1.55 ± 0.40 0.63
Triglycerides (mmol/L) 1.05 (0.80) 1.02 (0.80) 0.73
HOMA IR(mU*mmol/L2)* 2.8 (1.8) 2.8 (1.7) 0.82
Creatinine (μmol/L ) 97.2 ± 17.7 88.4 ± 17.7 0.11
Estimated glomerular filtration rate (ml/min) 65.3 ± 20.6 61.4 ± 16.4 0.04
Leptin (ng/mL) 7 (7) 8.8 (11) 0.002

Data expressed as percentage, mean ± SD or median (interquartile range).

*

Homeostasis Model Assessment for Insulin Resistance.